부산대학교 도서관

Although field stings could be life-threatening for patients with insect venom allergy and despite the availability of venom immunotherapy (VIT) as an effective causal treatment, poor therapy adherence has been observed in our country.[1] Venom immunotherapy is effective in 77%-84% of patients treated with honeybee venom and in 91%-96% of patients receiving vespid venom.[2] Adverse events are usually rare and mild, and symptoms occur in only 4.3%-11.4% of patients during the up-dosing.[3] Our 7-week outpatient protocol proved to be safe and effective in patients pretreated with antihistamines and is practical as well as efficient in terms of time and costs for patients and medical staff, which will lead to a better patient acceptance of VIT. [Extracted from the article]